Read more
This is a practical overview and resource guide for the design and measurement of pharmaceutical relationship marketing (RM) programs. It contains descriptions of each aspect of pharmaceutical RM design and measurement, including a running case study with follow-up exercises. The author has also conducted interviews from several pharmaceutical mark
List of contents
Chapter 1 Healthcare Trends and Relationship Marketing�€�s Role; Chapter 2 Foundations of Relationship Marketing; Chapter 3 Discovery: Situation Assessment; Chapter 4 Strategy: Planning the Relationship Marketing Program; Chapter 5 Analytics Planning for Relationship Marketing; Chapter 6 Execution: Placing in the Marketplace; Chapter 7 Measurement of Healthcare Relationship Marketing Programs; Chapter 8 Optimization and the New Cycle; Chapter 9 Conclusions and the Future;
About the author
Dr Ira J. Haimowitz is Executive Vice President, Analytics and Operations, at The CementBloc, a leading health and wellness communications agency. For over 20 years, he has provided healthcare clients innovative solutions for relationship marketing, segmentation, operations, measurement, and optimization. He has also enabled clients to evaluate the return on investment of their multichannel consumer and professional advertising campaigns. Prior to joining The CementBloc, Ira was Vice President, Group Director of Insights and Optimization at Wunderman, leading a team with primary responsibility for healthcare clients. Ira has also spent 9 years on the manufacturer side as a Director and Team Leader for pharmaceutical companies Pfizer and Organon. Ira Received his Ph.D. from the Massachusetts institute of Technology in Computer Science (medical emphasis) in 1994.
Summary
This is a practical overview and resource guide for the design and measurement of pharmaceutical relationship marketing (RM) programs. It contains descriptions of each aspect of pharmaceutical RM design and measurement, including a running case study with follow-up exercises. The author has also conducted interviews from several pharmaceutical mark
